Biocon

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE376G01013
  • NSEID: BIOCON
  • BSEID: 532523
INR
385.00
5 (1.32%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 79.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Ipca Labs
Gland Pharma
Glenmark Pharma
Abbott India
Anthem Bioscienc
Aurobindo Pharma
Lupin
Glaxosmi. Pharma
Mankind Pharma
Alkem Lab
Biocon

Why is Biocon Ltd. ?

1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.47 times
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.47 times
  • The company has been able to generate a Return on Equity (avg) of 4.95% signifying low profitability per unit of shareholders funds
2
Flat results in Jun 26
  • PBT LESS OI(Q) At Rs 86.60 cr has Fallen at -31.9% (vs previous 4Q average)
  • ROCE(HY) Lowest at 3.72%
  • PAT(Q) At Rs 154.60 cr has Fallen at -19.5% (vs previous 4Q average)
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Biocon for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Biocon
4.52%
0.18
25.23%
Sensex
-10.5%
-0.78
13.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
19.16%
EBIT Growth (5y)
11.24%
EBIT to Interest (avg)
4.69
Debt to EBITDA (avg)
4.70
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.43
Tax Ratio
13.00%
Dividend Payout Ratio
5.92%
Pledged Shares
0
Institutional Holding
31.53%
ROCE (avg)
5.99%
ROE (avg)
4.95%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
72
Industry P/E
37
Price to Book Value
1.84
EV to EBIT
49.95
EV to EBITDA
21.01
EV to Capital Employed
1.63
EV to Sales
4.29
PEG Ratio
0.74
Dividend Yield
0.13%
ROCE (Latest)
3.29%
ROE (Latest)
2.26%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
PAT(9M)

Higher at Rs 782.21 Cr

DEBT-EQUITY RATIO(HY)

Lowest at 0.45 times

-9What is not working for the Company
PBT LESS OI(Q)

At Rs 86.60 cr has Fallen at -31.9% (vs previous 4Q average

ROCE(HY)

Lowest at 3.72%

PAT(Q)

At Rs 154.60 cr has Fallen at -19.5% (vs previous 4Q average

NON-OPERATING INCOME(Q)

is 38.63 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Biocon

Debt-Equity Ratio - Half Yearly
Lowest at 0.45 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Biocon

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 86.60 cr has Fallen at -31.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 127.08 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 154.60 cr has Fallen at -19.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 192.14 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Non Operating Income - Quarterly
is 38.63 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT